HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Erythrokeratodermia variabilis: report of two cases and a novel missense variant in GJB4 encoding connexin 30.3.

Abstract
Erythrokeratodermia variabilis (EKV) is characterized by migrating red patches resembling a geographical map, and by localized or generalized hyperkeratosis with scaling of the skin. The onset is usually at birth or during infancy, and the disease persists throughout life. EKV is mainly inherited as an autosomal dominant disease, although recessive transmission has occasionally been reported. Mutations associated with EKV have been identified in the connexin (Cx) genes GJB3 (Cx31) and GJB4 (Cx30.3), however, several cases of EKV have been tested negative for mutations in these two Cx genes. Here, we report our findings of the clinical, histological, and molecular examinations performed in two unrelated sporadic cases of EKV. The molecular screening involved bidirectional sequencing of the coding regions of the GJB3 and GJB4 genes and revealed the existence of a novel c.295G>A missense variant in the GJB4 gene found in homozygosity in one case. The substitution was found to result in a p.E99K change of the Cx30.3 protein, an alteration predicted to have a benign rather than a damaging effect on the protein function.
AuthorsHaris Kokotas, Konstantina Papagiannaki, Maria Grigoriadou, Michael B Petersen, Alexandra Katsarou
JournalEuropean journal of dermatology : EJD (Eur J Dermatol) 2012 Mar-Apr Vol. 22 Issue 2 Pg. 182-6 ISSN: 1167-1122 [Print] France
PMID22266302 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Connexins
  • GJB3 protein, human
  • connexin 30.3
Topics
  • Adult
  • Child, Preschool
  • Connexins (genetics)
  • Erythrokeratodermia Variabilis (genetics, pathology)
  • Female
  • Humans
  • Mutation, Missense

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: